Federated Hermes’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-937,250
| Closed | -$18M | – | 2179 |
|
|
2024
Q3 | $18M | Buy |
937,250
+281,000
| +43% | +$5.41M | 0.04% | 451 |
|
|
2024
Q2 | $13.5M | Buy |
656,250
+117,536
| +22% | +$2.41M | 0.03% | 479 |
|
|
2024
Q1 | $12.8M | Buy |
+538,714
| New | +$12.8M | 0.03% | 517 |
|
|
2020
Q2 | – | Sell |
-67
| Closed | -$1K | – | 2364 |
|
|
2020
Q1 | $1K | Sell |
67
-313
| -82% | -$4.67K | ﹤0.01% | 2148 |
|
|
2019
Q4 | $3K | Sell |
380
-248
| -39% | -$1.96K | ﹤0.01% | 2003 |
|
|
2019
Q3 | $5K | Sell |
628
-70
| -10% | -$557 | ﹤0.01% | 1951 |
|
|
2019
Q2 | $6K | Buy |
698
+125
| +22% | +$1.07K | ﹤0.01% | 1962 |
|
|
2019
Q1 | $3K | Hold |
573
| – | – | ﹤0.01% | 2040 |
|
|
2018
Q4 | $3K | Buy |
573
+105
| +22% | +$550 | ﹤0.01% | 2050 |
|
|
2018
Q3 | $4K | Buy |
468
+241
| +106% | +$2.06K | ﹤0.01% | 2089 |
|
|
2018
Q2 | $2K | Sell |
227
-258
| -53% | -$2.27K | ﹤0.01% | 2112 |
|
|
2018
Q1 | $7K | Buy |
+485
| New | +$7K | ﹤0.01% | 1929 |
|